WHO ICTRP trial
The saftey and efficacy of intradermal injection of type A butulinum toxin in…
IRCT20200425047202N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20200425047202N1 |
|---|---|
| Public title | The saftey and efficacy of intradermal injection of type A butulinum toxin in chemotherapy induced peripheral neuropathy |
| Scientific title | The saftey and efficacy of intradermal injection of type A butulinum toxin in chemotherapy induced peripheral neuropathy |
| Primary sponsor | Shahid Beheshti University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Chemotherapy induced neuropathy. |
| Interventions | Intervention 1: injection of 150 units of butulinum toxin type A in 2 ml normal saline at 10 points of palmar side of one hand intradermally. Intervention 2: Control group: no injections. |
| Registration date | Jul 7, 2020 |
| Target size | 40 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: